Carcinoma intraductal de próstata concomitante y respuesta al tratamiento hormonal en el carcinoma de próstata metastásico

Culp, 2020, Recent global patterns in prostate cancer incidence and mortality rates, Eur Urol., 77, 38, 10.1016/j.eururo.2019.08.005 Cetin, 2010, Recent time trends in the epidemiology of stage IV prostate cancer in the United States: analysis of data from the Surveillance, Epidemiology, and End Results Program, Urology., 75, 1396, 10.1016/j.urology.2009.07.1360 Cózar, 2013, Registro Nacional de cáncer de próstata 2010 en España, Actas Urol Esp., 37, 12, 10.1016/j.acuro.2012.06.006 Andriole, 2009, Mortality results from a randomized prostate-cancer screening trial, N Engl J Med., 360, 1310, 10.1056/NEJMoa0810696 Schröder, 2009, Screening and prostate-cancer mortality in a randomized European study, N Engl J Med., 360, 1320, 10.1056/NEJMoa0810084 Guo, 2006, Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance, Mod Pathol., 19, 1528, 10.1038/modpathol.3800702 Cohen, 2000, Patterns of differentiation and proliferation in intraductal carcinoma of the prostate: significance for cancer progression, Prostate., 43, 11, 10.1002/(SICI)1097-0045(20000401)43:1<11::AID-PROS3>3.0.CO;2-B Robinson, 2010, Intraductal carcinoma of the prostate without invasive carcinoma on needle biopsy: emphasis on radical prostatectomy findings, J Urol., 184, 1328, 10.1016/j.juro.2010.06.017 Kovi, 1985, Ductal spread in prostatic carcinoma, Cancer., 56, 1566, 10.1002/1097-0142(19851001)56:7<1566::AID-CNCR2820560717>3.0.CO;2-Y Shah, 2010, Atypical cribriform lesions of the prostate: relationship to prostatic carcinoma and implication for diagnosis in prostate biopsies, Am J Surg Pathol., 34, 470, 10.1097/PAS.0b013e3181cfc44b Dawkins, 2000, Distinction between intraductal carcinoma of the prostate (IDC-P), high-grade dysplasia (PIN), and invasive prostatic adenocarcinoma, using molecular markers of cancer progression, Prostate., 44, 265, 10.1002/1097-0045(20000901)44:4<265::AID-PROS1>3.0.CO;2-I Kimura, 2014, Prognostic value of intraductal carcinoma of the prostate in radical prostatectomy specimens, Prostate., 74, 680, 10.1002/pros.22786 Pagliarulo, 2012, Contemporary role of androgen deprivation therapy for prostate cáncer, Eur Urol., 61, 11, 10.1016/j.eururo.2011.08.026 Mottet N. EAU guidelines on prostate cancer 2020. http://uroweb.org/wp-content/uploads/EAU-Guidelines-Prostate-Cancer-2020.pdf Zhao, 2017, The prognostic implication of intraductal carcinoma of the prostate in metastatic castration-resistant prostate cancer and its potential predictive value in those treated with docetaxel or abiraterone as first-line therapy, Oncotarget., 8 Gandaglia, 2015, Impact of the site of metastases on survival in patients with metastatic prostate cancer, Eur Urol., 68, 325, 10.1016/j.eururo.2014.07.020 McNeal, 1996, Spread of adenocarcinoma within prostatic ducts and acini. Morphologic and clinical correlations, Am J Surg Pathol., 20, 802, 10.1097/00000478-199607000-00003 Eisenhauer, 2009, New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1), Eur J Cancer., 45, 228, 10.1016/j.ejca.2008.10.026 Epstein, 2016, The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system, Am J Surg Pathol., 40, 244, 10.1097/PAS.0000000000000530 Humphrey, 2016, The 2016 WHO Classification of tumours of the urinary system and male genital organs-Part B: prostate and bladder tumours, Eur Urol., 70, 106, 10.1016/j.eururo.2016.02.028 Porter, 2017, Systematic review links the prevalence of intraductal carcinoma of the prostate to prostate cancer risk categories, Eur Urol., 72, 492, 10.1016/j.eururo.2017.03.013 Saeter, 2017, Intraductal carcinoma of the prostate on diagnostic needle biopsy predicts prostate cancer mortality: a population-based study, Prostate., 77, 859, 10.1002/pros.23326 Dinerman, 2017, Population-based study of the incidence and survival for intraductal carcinoma of the prostate, Urol Oncol., 35, 673, 10.1016/j.urolonc.2017.08.015 Zhao, 2015, Is there any prognostic impact of intraductal carcinoma of prostate in initial diagnosed aggressively metastatic prostate cancer?, Prostate., 75, 225, 10.1002/pros.22906 Chen, 2015, The presence and clinical implication of intraductal carcinoma of the prostate in CPRC patients, Prostate., 75, 1247, 10.1002/pros.23005 Yamamoto, 2017, Effect of chemotherapy on survival for intraductal carcinoma of the prostate (IDC-P) in patients with castration-resistant prostate cancer, J Clin Oncol., 35, 10.1200/JCO.2017.35.6_suppl.e601 Sweeney, 2015, Chemohormonal therapy in metastatic hormone-sensitive prostate cancer, N Engl J Med., 373, 737, 10.1056/NEJMoa1503747 Fizazi, 2017, Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer, N Engl J Med., 377, 352, 10.1056/NEJMoa1704174